+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Arthritis Monoclonal Antibodies Market Report 2025 - Product Thumbnail Image

Arthritis Monoclonal Antibodies Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Conjugated Monoclonal Antibodies Market Report 2025 - Product Thumbnail Image

Conjugated Monoclonal Antibodies Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Urothelial Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Urothelial Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Ulcerative Colitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
From
From
From
From
Ocular Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Ocular Drug Delivery - Global Strategic Business Report

  • Report
  • August 2025
  • 489 Pages
  • Global
From
Pediatric Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pediatric Drugs and Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 292 Pages
  • Global
From
From
Cell Therapy Market Report 2025 - Product Thumbnail Image

Cell Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Loading Indicator